calcimedica.com (CALI) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
CalciMedica, Inc. (CALI) mavjud moliyaviy rezervlaridan foydalangan holda yallig'lanishga qarshi davolash vositalarini ishlab chiqmoqda. Ushbu kunlik narxlar grafigi jarayonni kuzatishga yordam beradi, bunda ko'rsatkich hozirda 0.00 darajasida. Biznes hozirda foyda keltirmagan holda dori vositalarini sinovdan o'tkazishga e'tibor qaratgan, bu esa naqd pullarning to'liq sarflanishiga olib kelmoqda. Shu bilan birga, kompaniya maqsadli bozorga kirishni nazorat qiluvchi sanoat gigantlarining bosimiga duch kelmoqda.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_CALI_-_CalciMedica-Inc._-_Long-Term-Debt-to-Capital "CALI: CalciMedica Corp Uzoq muddatli qarzning kapitalga nisbati 11.10.2024 - 17.10.2026 | 👁️GURU.Markets👁️")
CalciMedica Inc (CALI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati CalciMedica, Inc.|CALI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati CalciMedica Corp|CALI - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati CalciMedica, Inc.|CALI - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi CalciMedica|Tezkor likvidlik ko‘rsatkichi calcimedica.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:calcimedica.com - CALI
Ushbu ko'rsatkich uzoq muddatli qarz majburiyatlarini emitentning kapitali bilan solishtiradi. Ushbu metrikaning kamayishi qarz yukining kamayganini va defolt xatarlarining minimallashtirilganini anglatadi. Uzoq muddatli qarzning kapitalga nisbati dinamikasi moliyaviy barqarorlikni real vaqt rejimida monitoring qilish imkonini beradi. CalciMedica, Inc. uchun mo'tadil qarz olish CRAC kanal inhibitorlarining himoyalangan nishasi bilan asoslanadi. Pankreatit terapiyasidagi patent monopoliyasi qarzlar xizmatini ko'rsatish uchun barqaror pul oqimini ta'minlaydi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|Pieris Corp (PVLA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|SVRA: Uzoq muddatli qarzning kapitalga nisbati|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning kapitalga nisbati ENGN|Uzoq muddatli qarzning o'z kapitaliga nisbati rapt.com RAPT|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati aclaristx.com (ACRS)|KYTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Tiziana Life Sciences Ltd. (TLSA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CABA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Ventyx Biosciences, Inc (VTYX)|THTX (Theratechnologies Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi AVTX (avalotx.com)|Uzoq muddatli qarzning kapitalga nisbati ELDN|Uzoq muddatli qarzdorlikning kapitalga nisbati Agenus, Inc.|Uzoq muddatli qarzning kapitalga nisbati CLYM (Climb Bio, Inc.)|ZURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|ADAG - Uzoq muddatli qarzning kapitalga nisbati|IMA (ikenaoncology.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Shattuck Labs - Uzoq muddatli qarzning kapitalga koeffitsiyenti|EQ (Equillium Inc) - Uzoq muddatli qarzning kapitalga nisbati|Connect Pharma (CNTB) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunic, Inc. (IMUX)|atarabio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati IFRX (InflaRx)|XFOR - Uzoq muddatli qarzning o'z kapitaliga nisbati|ACET: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Celularity Inc. CELU|INMB: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati barinthusbio.com|KZR (Kezar Life Sciences, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati SAB Biotherapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics plc (AKTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati ENLV (enlivex.com)|Uzoq muddatli qarzning kapitalga nisbati QTTB (Q32 Bio)|Uzoq muddatli qarzdorlikning kapitalga nisbati geovax.com (GOVX)|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati IBIO|CARM: Uzoq muddatli qarzning kapitalga nisbati|XTL Bio - Uzoq muddatli qarzning kapitalga koeffitsiyenti|BOLT (Bolt Biotherapeutics Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati HCW Biologics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Aptevo Therapeutics (APVO)|AIM (aimimmuno.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Aditxt, Inc. ADTX|GRI - Uzoq muddatli qarzning o'z kapitaliga nisbati|XORTX Therapeutics Inc. - Uzoq muddatli qarzning kapitalga nisbati|HIND - Uzoq muddatli qarzning kapitalga nisbati|REVB (Revelation Biosciences, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Indaptus Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SCNI (Scinai) - Uzoq muddatli qarzning kapitalga nisbati|Affimed Therapeutics (AFMD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzning o'z kapitaliga nisbati hookipapharma.com HOOK|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|ITOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|TCBP - Uzoq muddatli qarzning kapitalga nisbati|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati